Form 8-K - Current report:
SEC Accession No. 0001493152-24-041330
Filing Date
2024-10-16
Accepted
2024-10-16 17:20:31
Documents
15
Period of Report
2024-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46402
2 ex99-1.htm EX-99.1 11518
  Complete submission text file 0001493152-24-041330.txt   288914

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20241009.xsd EX-101.SCH 3918
4 XBRL DEFINITION FILE celu-20241009_def.xml EX-101.DEF 30245
5 XBRL LABEL FILE celu-20241009_lab.xml EX-101.LAB 37145
6 XBRL PRESENTATION FILE celu-20241009_pre.xml EX-101.PRE 27268
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6186
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 241375411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)